| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sierra Oncology, Inc. | Chief, Research & Early Dev | Stock Option (Right to Buy) | 12,250 | 28 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919122005484-kowalski-mark-2022-01-28 | Sierra Oncology, Inc. | 28 Jan 2022 | 1 | $0 | 4 | Chief, Research & Early Dev | 28 Jan 2022, 17:34 |